In 2026 DKSH Performance Materials Personal Care and Home Care team is now expanding our know-how, product range and service into high- performance pet care development, supporting manufacturers globally with ingredients, formulation design, and lab- led innovation.

Digital transformation has gradually reshaped industries worldwide, but in sectors like chemicals and materials, the shift has historically been slower. Christophe Cabarry, founder and CEO of SpecialChem, has been at the forefront of this transformation for over 25 years. Through this platform, he has bridged the gap between traditional chemical companies and the evolving demands of digitally empowered buyers.

Fi Asia 2025 has confirmed what many in the industry anticipated: the next frontier in food innovation is health and functionality. Attendees were highly focused on exploring nutraceuticals, dietary supplements, and functional food ingredients designed to meet growing consumer demand for wellness, performance, and preventive care.

At DKSH, our Oligonucleotide Solutions combine nucleosides, derivatives, phosphoramidites, liposomes, and advanced delivery excipients to provide a reliable backbone for oligonucleotide R&D and commercial development.

The biopharma industry is at a crossroads: rising costs and regulatory complexity demand new approaches to efficiency. For research teams and executives alike, the imperative is clear — strengthen supply chains, rethink sourcing strategies, and adopt smarter innovation models.

At DKSH Performance Materials, we believe that connecting businesses with the right solutions should be fast, smart, and seamless. We are thrilled to share that our digital customer platform, DKSH Discover, has been recognized for doing just that by winning two prestigious awards at the Marketing Interactive Asia E-Commerce Awards 2025.

Analysts forecast oncology mRNA will be a multi-billion-dollar market by 2030. The winners won’t just have the best science — they’ll have supply chains that regulators, clinicians, and payers trust.

We’re bringing innovation to Paris this December! Visit us at Booth 40D50 to discover what’s next in food ingredients. Stay tuned—something exciting is cooking.

Bioprocessing leaders today face mounting pressure: how to accelerate development, secure yields, and ensure compliance in a cost-sensitive, highly regulated market. The right ingredients are no longer a commodity purchase — they are the strategic backbone of speed, yield, and regulatory success. Here are the Top Bioprocessing Pressures and how DKSH’s ingredient portfolio directly addresses them!

As cell and gene therapies revolutionize treatment for cancer, rare diseases, and immunological disorders, DKSH is committed to supporting researchers and manufacturers with a specialized product range that meets the evolving demands of this dynamic field.

When it comes to skincare, Vitamin C is one of the most popular and trusted ingredients. From brightening dark spots, reducing wrinkles and boosting collagen, it has earned its place as a gold standard in dermatology and cosmetic science. But here is the challenge, not all Vitamin C is stable or gentle. Pure ascorbic acid can oxidize quickly and often causes irritation or is too harsh when used at high concentrations. Thats where AA2G™ (Ascorbyl Glucoside), developed by Nagase Viita.

Mini DuoCol® 2% Solution was developed by Trautec, a U.S. biotech innovator holding exclusive IP in recombinant collagen, in collaboration with the DKSH North America Innovation Center. Their breakthrough wasn’t just producing collagen through fermentation, it was making it scalable, high-purity, and fully compatible with human skin. Today, DKSH brings this breakthrough to market with exclusive global distribution of Mini DuoCol® 2% Solution.